Latest news
12-10-2022 - ACTION Consortium International Neuroblastoma Research Initiative Open for Applications
New grant programme offering up to $2 million for collaborative projects to develop innovative new therapies for children with neuroblastoma and improve and/or advance the clinical trials framework for neuroblastoma research.
The ACTION Consortium (Advancing Clinical Trial Implementation and Optimisation in Neuroblastoma) is a new research funding group founded by five non-profit organisations (Anticancer Fund, EVAN Foundation, Kindred Foundation, Solving Kids’ Cancer UK and Zoé4Life) to support the development of therapies for neuroblastoma in children and improve the drug development and evaluation framework to accelerate the delivery of clinical trials for neuroblastoma research.
[...]